Powerhome Solar and Roofing

POWERHOME Solar, LLC is a leader in the residential solar installation space. It was ranked 7th nationally for residential solar contracting and as the 96th fastest growing company in the US. The company is headquartered in Mooresville, North Carolina and has operations in North Carolina, South Carolina, Virginia, Michigan and Ohio with expected growth in a number of other states.

Trivest is a private equity firm that makes both controlling and minority stake investments in high quality companies with strong management teams, sustainable competitive advantages and high growth prospects. The company recently closed its 6th fund, which totals $600 million. Trivest is headquartered in Coral Gables, FL.

POWERHOME Solar pursued a growth equity investment in order to accelerate its growth in existing and new states.

Cypress Associates LLC acted as financial advisor to POWERHOME Solar in its sale of Series A Convertible Preferred Stock to Trivest.

RetailNext

Cypress Associates LLC acted as financial advisor to the Independent Committee of the Board of Directors of RetailNext and rendered a fairness opinion in connection with its recapitalization and refinancing transactions

Urology Specialists of West Florida

Urology Specialists of West Florida, LLP (“USWF”) is the largest urology practice in greater St. Petersburg / Clearwater and is a leading provider of radiation therapy treatment in West Florida through its Radiation Oncology Center (the “Center”). USWF has operated its Center in Clearwater, FL since March 2009 and provides a comfortable experience to prostate cancer patients while delivering the highest quality of care. Prior to the transaction, the Center was wholly owned by USWF.

McKesson Specialty Health, through its wholly owned US Oncology / Vantage Oncology subsidiaries, develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company seeks to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. McKesson Specialty Health operates over 140 treatment facilities in 25 states, and has a network of providers which includes 200 Urologists, 250 Radiation Oncologists and 800 Medical Oncologists.

As a result of the transaction, USWF and McKesson plan to grow high quality radiation therapy services in West Florida through a combination of strategic insight, application of clinical best-practices and a patient-centered approach.

Cypress Associates LLC acted as financial advisor to USWF in the sale of its radiation assets to a new company jointly owned by USWF and McKesson.

nPhase Inc

nPhase, Inc. is a SaaS-based software company formed to commercialize a cloud-enabled, Part 11 certified clinical trials management software solution using Vanderbilt University’s world renown, server-based REDCap electronic data capture application which collects, manage and reports data for clinical research trials.

At transaction closing, REDCap had approximately 300,000 users at 1,500 institutions, including many of the most well-known academic research organizations in the world (e.g., Harvard, Yale, Stanford, Johns Hopkins, Duke, Mayo Clinic, Cleveland Clinic, Children’s Hospital of Philadelphia, Vanderbilt).

In 2015, nPhase was selected by Vanderbilt to perform REDCap’s software enhancements and bring to market the FDA-certified clinical trials management software solution. nPhase operates under a long-term, exclusive worldwide license granted by Vanderbilt.

In December 2015, with the assistance of Cypress, nPhase successfully structured and closed a private placement of Series A Convertible Preferred Stock purchased by WRD Capital, Selous Ventures, Solidus, and Vanderbilt University.

Cypress acted as placement agent to nPhase in connection with the Company’s equity financing transaction.

In the course of the transaction, Cypress also provided value-add financial advisory expertise, including negotiating key terms of the transaction such as governance provisions and investor voting rights.

nPhase Inc

nPhase, Inc. is a SaaS-based software company which sells REDCap Cloud, a cloud-enabled, Part 11 certified clinical trials management software solution, to healthcare organizations deploying patient engagement-focused data capture strategies.

REDCap Cloud is used by pharmaceutical companies and contract research organizations (CROs) to collect, manage and report data for clinical research trials to be filed with the FDA and by healthcare providers to capture other patient-related data (such as patient reported outcomes data used for value-based pricing models).

REDCap Cloud was launched commercially in the fall of 2016 and uses (via an exclusive license) Vanderbilt University’s world renown, server-based REDCap electronic data capture application as its foundation. REDCap Cloud has established a solid and quickly growing customer base of pharmaceutical companies, CROs and other healthcare providers.

At transaction closing, REDCap’s Vanderbilt consortium(using the server-based software) was comprised of approximately 560,000 users at 2,400 institutions, including many of the most well-known academic research organizations in the world (e.g., Harvard, Yale, Stanford, Johns Hopkins, Duke, Mayo Clinic, Cleveland Clinic, Children’s Hospital of Philadelphia, Vanderbilt).

In May 2017, with the assistance of Cypress, nPhase successfully structured and closed a follow-on private placement of Series B Convertible Preferred Stock purchased by existing investors, including WRD Capital and Vanderbilt University.

In December 2015, with the assistance of Cypress, nPhase successfully structured and closed a private placement of Series A Convertible Preferred Stock purchased by WRD Capital, Selous Ventures, Solidus, and Vanderbilt University.

Cypress acted as placement agent to nPhase in connection with its Series A and Series B equity financing transactions.

EdSolutions

EdSolutions is a strategy-consulting firm focused on the education industry, both public school systems and technology companies whose products and services are useful to professional educators. They seek to assist in the development and implementation of technology by bridging the gap between the producers of educational technology and its most important users.

Cypress Associates acted as financial advisor and private placement agent EdSolutions on its working capital facility.

Reading International

Reading International, Inc develops, owns and operates cinemas and live theaters and other real estate assets in the United States, Australia and New Zealand.

Cypress acted as financial advisor on Reading International Trust preferred private placement.

Schultze

Schultze Asset Management, LLC was founded by George J. Schultze in 1998 to exploit opportunities in distressed securities by investing long and/or short in the securities of companies undergoing restructurings or reorganizations. Our focus is special situation investing in financially troubled and distressed credits.

As a U.S. distressed securities manager, located in New York and focusing on U.S. firms, they have the flexibility to invest in any part of the capital structure and at any point during the restructuring process. Through a highly disciplined alternative investment process, they seek to identify mispriced securities of companies in distress when one or more catalyst events are likely to drive values substantially towards fair value.

Cypress acted as Marketing Agent on behalf of Schultze Asset Management for a $20mm investment in Schultze Offshore Fund by a major institutional investor.

MMIS

MMIS, Inc. is a leading SaaS-based enterprise global compliance software company to the pharmaceutical and medical device industry internationally. The Company’s product suite is comprised of high value-added business collaboration and compliance software modules which create a unique end-to-end solution.

The Company’s compliance solutions are in high demand from clients due to the current requirements for pharmaceutical and medical device companies to comply with “open payments” regulations under The Sunshine Act in the U.S. and similar regulations globally. MMIS, Inc. pursued an equity financing to further accelerate its growth and capitalize on the favorable market environment for its services.

With the assistance of Cypress, MMIS, Inc. successfully structured and executed a private placement of Series A-1 Convertible Preferred Stock purchased by EDG Partners Fund II, L.P.

Cypress acted as the exclusive placement agent to MMIS, Inc. in connection with the Company’s growth equity recapitalization transaction.

In the course of the transaction, Cypress also provided value-add financial advisory expertise, including negotiating the valuation used to determine EDG’s pro forma equity ownership in the recapitalized company and developing the strategy to redeem all outstanding shares from owners of the Company’s previously outstanding preferred stock.

Gilbert Global Equity Partners

Gilbert Global Equity Capital, a leading private equity investment firm, completed the dividend recapitalization of its portfolio company, CPM Holdings, Inc., the world’s leading provider of process equipment and engineered solutions for the oilseed, animal feed, and alternative energy markets.

The recapitalization transaction was funded through a new Senior Secured Facilities of $405 million. The Company will utilize the proceeds from the Senior Secured Credit Facilities along with existing cash reserves to refinance existing debt and issue a dividend to its shareholders.

The transaction provides CPM with enhanced financial flexibility, allowing it to continue its strategic growth initiatives, while also enabling Gilbert Global Equity Capital and its limited partners, the Company’s controlling shareholder, to realize a return of capital substantially in excess of its original investment while leaving its ownership stake unchanged.

Cypress acted as financial advisor to Gilbert Global Equity Capital LLC in connection with the dividend recapitalization of CPM Holdings.